Synopsis
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
A Chlorphenesin Carbamate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chlorphenesin Carbamate, including repackagers and relabelers. The FDA regulates Chlorphenesin Carbamate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chlorphenesin Carbamate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Chlorphenesin Carbamate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Chlorphenesin Carbamate supplier is an individual or a company that provides Chlorphenesin Carbamate active pharmaceutical ingredient (API) or Chlorphenesin Carbamate finished formulations upon request. The Chlorphenesin Carbamate suppliers may include Chlorphenesin Carbamate API manufacturers, exporters, distributors and traders.
click here to find a list of Chlorphenesin Carbamate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Chlorphenesin Carbamate DMF (Drug Master File) is a document detailing the whole manufacturing process of Chlorphenesin Carbamate active pharmaceutical ingredient (API) in detail. Different forms of Chlorphenesin Carbamate DMFs exist exist since differing nations have different regulations, such as Chlorphenesin Carbamate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Chlorphenesin Carbamate DMF submitted to regulatory agencies in the US is known as a USDMF. Chlorphenesin Carbamate USDMF includes data on Chlorphenesin Carbamate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Chlorphenesin Carbamate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Chlorphenesin Carbamate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Chlorphenesin Carbamate Drug Master File in Japan (Chlorphenesin Carbamate JDMF) empowers Chlorphenesin Carbamate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Chlorphenesin Carbamate JDMF during the approval evaluation for pharmaceutical products. At the time of Chlorphenesin Carbamate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Chlorphenesin Carbamate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Chlorphenesin Carbamate Drug Master File in Korea (Chlorphenesin Carbamate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Chlorphenesin Carbamate. The MFDS reviews the Chlorphenesin Carbamate KDMF as part of the drug registration process and uses the information provided in the Chlorphenesin Carbamate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Chlorphenesin Carbamate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Chlorphenesin Carbamate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Chlorphenesin Carbamate suppliers with KDMF on PharmaCompass.
Chlorphenesin Carbamate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chlorphenesin Carbamate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Chlorphenesin Carbamate GMP manufacturer or Chlorphenesin Carbamate GMP API supplier for your needs.
A Chlorphenesin Carbamate CoA (Certificate of Analysis) is a formal document that attests to Chlorphenesin Carbamate's compliance with Chlorphenesin Carbamate specifications and serves as a tool for batch-level quality control.
Chlorphenesin Carbamate CoA mostly includes findings from lab analyses of a specific batch. For each Chlorphenesin Carbamate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chlorphenesin Carbamate may be tested according to a variety of international standards, such as European Pharmacopoeia (Chlorphenesin Carbamate EP), Chlorphenesin Carbamate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chlorphenesin Carbamate USP).
LOOKING FOR A SUPPLIER?
